Isomab Ltd logo

Isomab Ltd jobs and careers

Nottingham, United Kingdom

As of October 23, 2026, Isomab Ltd has no open roles listed.

About Isomab Ltd

IsomAb is taking a different approach to identify, evaluate and develop isoform specific antibodies to treat disease where patients currently have limited or no treatment options. IsomAb is developing isoform specific antibodies and it has identified, using a combined bioinformatics/knowledge-based platform approach, ISM-001 which specifically inhibits the VEGF-A165b isoform of Vascular Endothelial Growth Factor-A (VEGF-A); based on 20 years of research by our two Founders, the evidence shows reducing serum levels of VEGF-A165b is key to ensuring new blood vessel formation in patients with ischemic disease.

Founded in 2022 by David Bates and Stephen Harper.

Founded
2022
Employees
1 to 10
Total funding
$7.5M
Headquarters
Nottingham

Leadership

The top of Isomab Ltd's org chart, with how many people report into each leader.

JT

Jackie Turnbull

CEO

4 reports

DMPhoto of Dr Kishor Modha

Dr Kishor Modha

Vice President Of Product Development

2 reports

ALPhoto of Anker Lundemose

Anker Lundemose

Executive Director

Isomab Ltd jobs: common questions

Is Isomab Ltd hiring right now?
Isomab Ltd has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on Isomab Ltd's careers site.
Where is Isomab Ltd headquartered?
Isomab Ltd is headquartered in Nottingham, United Kingdom and was founded in 2022.
Who leads Isomab Ltd?
Jackie Turnbull, CEO, is at the top of Isomab Ltd's org chart.
How do I apply for a job at Isomab Ltd?
Pick a role on Isomab Ltd's TheJobsMap page and select Apply. Every listing links to the original posting on Isomab Ltd's own careers site, so you apply directly with the employer.